Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Achieve Life Sciences, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −3 vs. Q2 2023
- Shares held
- 3.12M
- −452.0K (−12.7%) vs. Q2 2023
- Total value
- $13.4M
- −$5.14M (−27.7%) vs. Q2 2023
- New holders
- 5
- 8 more added
- Sold out
- 8
- 13 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACHV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $538.7M |
| Q1 2026 | 81 | $63.6M |
| Q4 2025 | 77 | $115.3M |
| Q3 2025 | 66 | $48.9M |
| Q2 2025 | 66 | $59.3M |
| Q1 2025 | 72 | $38.4M |
| Q4 2024 | 70 | $57.5M |
| Q3 2024 | 64 | $81.2M |
| Q2 2024 | 56 | $78.4M |
| Q1 2024 | 41 | $64.9M |
| Q4 2023 | 29 | $11.2M |
| Q3 2023 | 35 | $13.4M |
| Q2 2023 | 39 | $18.6M |
| Q1 2023 | 31 | $16.6M |
| Q4 2022 | 28 | $4.90M |
| Q3 2022 | 28 | $7.00M |
| Q2 2022 | 31 | $9.97M |
| Q1 2022 | 33 | $14.6M |
| Q4 2021 | 29 | $14.9M |
| Q3 2021 | 32 | $15.2M |
| Q2 2021 | 29 | $17.5M |
| Q1 2021 | 16 | $11.7M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Achieve Life Sciences, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Shay Capital LLC | 741,000 | $3.19M | 0.94% | −35,600−4.6% | Reduced |
| Vanguard Group Inc | 593,953 | $2.55M | 0.00% | +16,160+2.8% | Added |
| AWM Investment Company, Inc. | 272,500 | $1.17M | 0.17% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 248,099 | $1.07M | 0.15% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 184,925 | $795.4K | 0.00% | +22,637+13.9% | Added |
| LPL Financial LLC | 164,500 | $707.4K | 0.00% | +16,500+11.1% | Added |
| Raymond James & Associates | 146,100 | $628.2K | 0.00% | +8,615+6.3% | Added |
| Perkins Capital Management Inc | 125,212 | $538.0K | 0.53% | −1,000−0.8% | Reduced |
| Wells Fargo & Company | 120,981 | $520.2K | 0.00% | −1,512−1.2% | Reduced |
| Diametric Capital, LP | 79,210 | $340.6K | 0.14% | −4,868−5.8% | Reduced |
| Northern Trust Corp | 78,957 | $339.5K | 0.00% | +5,379+7.3% | Added |
| Walleye Capital LLC | 69,659 | $299.5K | 0.00% | −25,374−26.7% | Reduced |
| State Street Corp | 63,316 | $272.3K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 52,585 | $226.1K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 25,429 | $109.3K | 0.01% | −1,563−5.8% | Reduced |
| Millennium Management LLC | 23,605 | $101.5K | 0.00% | +23,605 | New |
| Renaissance Technologies LLC | 22,100 | $95.0K | 0.00% | −17,500−44.2% | Reduced |
| Manchester Financial Inc | 18,600 | $80.0K | 0.02% | +5,675+43.9% | Added |
| Squarepoint Ops LLC | 12,474 | $53.6K | 0.00% | −9,498−43.2% | Reduced |
| Bank of New York Mellon Corp | 11,441 | $49.2K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 11,290 | $48.5K | 0.00% | +11,290 | New |
| Advisor Group Holdings, Inc. | 10,852 | $46.7K | 0.00% | +6,400+143.8% | Added |
| Group One Trading, L.P. | 10,030 | $43.1K | 0.00% | −3,576−26.3% | Reduced |
| Citadel Advisors LLC | 6,787 | $29.2K | 0.00% | −7,902−53.8% | Reduced |
| Bank of America Corp | 6,519 | $28.0K | 0.00% | 00.0% | Unchanged |
| Comerica Bank | 5,500 | $23.6K | 0.00% | +5,500 | New |
| Tower Research Capital LLC (TRC) | 3,618 | $15.6K | 0.00% | −15,820−81.4% | Reduced |
| Stephens Consulting, LLC | 3,000 | $12.9K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 2,200 | $9.46K | 0.00% | −1,600−42.1% | Reduced |
| UBS Group AG | 1,259 | $5.41K | 0.00% | +1,093+658.4% | Added |
| Simplex Trading, LLC | 485 | $2.00K | 0.00% | −1,572−76.4% | Reduced |
| Cutler Group LP | 479 | $2.00K | 0.00% | 00.0% | Unchanged |
| Godsey & Gibb Associates | 453 | $1.95K | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 100 | $430 | 0.00% | +100 | New |
| Qube Research & Technologies Ltd | 1 | $4 | 0.00% | +1 | New |
| National Asset Management, Inc. | 0 | $0 | 0.00% | −216,216−100.0% | Sold out |
| One68 Global Capital, LLC | 0 | $0 | 0.00% | −96,700−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −91,963−100.0% | Sold out |
| Beaumont Financial Advisors, LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,841−100.0% | Sold out |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −11,200−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −4,163−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| BerganKDV Wealth Management, LLC | – | – | – | – | Not filed |